July 2020

Copyright ‘Strikes’ Cricket: Films Division’s Tryst with Old Cricket Clips

/ By / Copyright

The Films Division of India (‘Films Division’) holds copyright in a large number of old clips pertaining to cricket, primarily in form of newsreels or short documentaries about some series or events. As per his interview with The Hindu, a cricket fan Mr. Jairaj Galagali ordered these clips, after much bureaucratic hassle, upon making the required payments for the same. He subsequently uploaded these clips on his YouTube channel. In his videos, alongside the clips, he used to provide a social […]

Copyright ‘Strikes’ Cricket: Films Division’s Tryst with Old Cricket Clips Read More »

Delhi HC Refuses Interim Injunction against Use of Acronym ‘TCV’ for a Typhoid Vaccine: Leaves Acquired Distinctiveness Question Unanswered?

/ By / Trademark

We’re pleased to bring to you a guest post by Devangini Rai, analysing a recent Delhi High Court order that refused to grant an interim injunction against the use of the acronym ‘TCV’ in relation to a typhoid vaccine. Devangini is a 5th Year student at University School of Law and Legal Studies, Guru Gobind Singh Indraprastha University, New Delhi.     Delhi HC Refuses Interim Injunction against Use of Trademark ‘TCV’ for a Typhoid Vaccine: Leaves Acquired Distinctiveness Question

Delhi HC Refuses Interim Injunction against Use of Acronym ‘TCV’ for a Typhoid Vaccine: Leaves Acquired Distinctiveness Question Unanswered? Read More »

SpicyIP Weekly Review (July 6 – 12)

/ By / Copyright, Drug Regulation, Others, Patent, Trademark

Topical Highlight Telegram Copyright Infringement Case: India’s Chance to Seek Inspiration from Foreign Principles In a guest post, Abhishek Iyer discussed the issue of intermediary liability in light of the Telegram copyright infringement case. The post first discusses the burden of knowledge with respect to e-notices to understand Telegram’s liability given the requirement of ‘specific and actual knowledge’ of intermediaries with respect to infringement of copyrighted material. The doctrine of inducement used in US Courts is discussed to determine Telegram’s

SpicyIP Weekly Review (July 6 – 12) Read More »

From Iancu v. Brunetti to Constantin Film: Should Morality Interfere with Trademark law?

/ By / Trademark

We’re pleased to bring to you a guest post by our fellowship applicant, Adyasha Samal. Adyasha is a 4th year student at Hidayatullah National Law University, Raipur. This is her first submission for the Fellowship. In this post, she explores issues relating to morality based prohibitions in trademark law in light of the Court of Justice of the European Union’s decision permitting the registration of the ‘Fack Ju Göhte’ mark earlier this year. We’ve had several posts on the issue of

From Iancu v. Brunetti to Constantin Film: Should Morality Interfere with Trademark law? Read More »

Telegram Copyright Infringement Case: India’s Chance to Seek Inspiration from Foreign Principles

/ By / Copyright

We’re pleased to bring to you a guest post by Abhishek Iyer. Abhishek is a 3rd year student at the Gujarat National Law University (GNLU), Gandhinagar. Telegram Copyright Infringement Case: India’s Chance to Seek Inspiration from Foreign Principles Abhishek Iyer Circulation of e-newspapers and its validity under copyright law have been regularly put on debate, SpicyIP had recently discussed it here. On similar lines, popular news publisher Jagran Prakashan Limited (‘Plaintiff’), found their e-paper being freely circulated online, through messaging

Telegram Copyright Infringement Case: India’s Chance to Seek Inspiration from Foreign Principles Read More »

DPCO’s Para 32 Conundrum Continues: Price Control Exemptions for Newly Patented Drugs

/ By / Drug Regulation, Patent

Earlier in February, I had written about a petition filed by AIDAN challenging Paragraph 32 of the Drug (Prices Control) Order 2013 (DPCO) and the Drug (Prices Control) Amendment Order, 2019. Para. 32 of the DPCO creates a provision for the exemption of certain drugs from price control. One of the exemptions under Para. 32, brought in through the 2019 amendment, is for ‘new drugs’ patented under the Indian Patents Act, 1970. The latest provision, after the amendment, reads –

DPCO’s Para 32 Conundrum Continues: Price Control Exemptions for Newly Patented Drugs Read More »

Book Release: ‘Imperfect Recollections: The Indian Supreme Court on Trade Mark Law’

/ By / Trademark

We’re pleased to bring to you a guest post by Eashan Ghosh on his recently released book ‘Imperfect Recollections: The Indian Supreme Court on Trade Mark Law’. Eashan has been practicing as an intellectual property advocate and consultant in New Delhi since 2011, and teaches a seminar on intellectual property law at National Law University, Delhi. Eashan writes about Indian intellectual property law, including a monthly review of Delhi High Court judgments, on his Medium page. He has written several guest

Book Release: ‘Imperfect Recollections: The Indian Supreme Court on Trade Mark Law’ Read More »

SpicyIP Weekly Review (June 29 – July 5)

/ By / Copyright, Others, Patent, Trademark

[This post has been authored by Rishabh Joshi, a 4th year student at Gujarat National Law University (GNLU), Gandhinagar.] Topical Highlights Nationalism, Drugs and Public Interest – Remdesivir and Beyond Swaraj highlights how nationalism can hinder public health in light of the ‘drug hoarding’ (Remdesivir) by the United States. He first starts by talking about how Remdesivir is not the most effective treatment for the COVID-19 virus as the improvement rate is not so high. He briefly discusses the intermingling

SpicyIP Weekly Review (June 29 – July 5) Read More »

Nationalism, Drugs and Public Interest – Remdesivir and Beyond

/ By / COVID-19, Drug Regulation, Patent

A few days ago, the US Department of Health and Human Services (HHS) announced that their President has struck an ‘amazing deal’ with Gilead, that ensured nearly all of Gilead’s projected production of Remdesivir for the next three months are secured by the US. “Nearly all” in this case, refers to 100% of Gilead’s projected production of Remdesivir for July, and 90% of the projected production for August and September. This is after US has already kept about 60% (940,000)

Nationalism, Drugs and Public Interest – Remdesivir and Beyond Read More »

Photo of Jay Manoj Sanklecha

A Look at the WTO Panel Report in ‘Saudi Arabia- Measures Concerning the Protection of Intellectual Property Rights’

/ By / Copyright, Others

Football fans may be aware of the joint statement last year by various sports bodies including Fifa, LaLiga, Premier League, and others, against the Saudi Arabia based beoutQ broadcaster for their unauthorized streaming of content on a commercial scale, as well as their (i.e., the copyright holders) inability to obtain legal counsel in Saudi Arabia in this matter, among other issues. In the meanwhile, Qatar had taken this matter to the WTO, and on 16th June 2020, the WTO Panel

A Look at the WTO Panel Report in ‘Saudi Arabia- Measures Concerning the Protection of Intellectual Property Rights’ Read More »

Scroll to Top